Physician

Internal Medicine

Dr. Louis Vaickus, MD

Louis Vaickus, MD works in the field of Internal Medicine. He went to medical school at Loyola University Chicago Stritch School of Medicine. Louis Vaickus is a published doctor as well. He has 38 publications published. The latest was: Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.

Publications

Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines.
Inbred and outbred mice have equivalent variability in a cockroach allergen-induced model of asthma.
Oral tolerance inhibits pulmonary eosinophilia in a cockroach allergen induced model of asthma: a randomized laboratory study.
Assessing pulmonary pathology by detailed examination of respiratory function.
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Recombinant interleukin-6 in the treatment of congenital thrombocytopenia associated with absent radii.
Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer.
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery.
Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.
Platelet transfusion and alternatives to transfusion in patients with malignancy.
Antiidiotype (Ab2) vaccine therapy for cutaneous T-cell lymphoma.
Carboplatin for small cell lung cancer: progress toward greater efficacy and reduced toxicity.
Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF)
Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.
Pericarditis induced by high-dose cytarabine therapy.
Murine autogeneic mixed lymphocyte culture. Role of culture conditions.
Analysis of human peripheral blood mononuclear cells bearing Fc receptors for the three major immunoglobulin isotypes.
Antiproliferative monoclonal antibodies: detection and initial characterization.
Nuclear magnetic resonance spectroscopy of plasma for the detection of head and neck cancer.
Antiproliferative mechanism of anti-class II monoclonal antibodies.
Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of hum...
Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.
Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease.
Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes.
Unusual gastrointestinal complications of interleukin-2 therapy.
Overview of monoclonal antibodies in the diagnosis and therapy of cancer.
Immune markers in hematologic malignancies.
Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer.
Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells.
Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.
Levalbuterol hydrochloride.
Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.
Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody.
Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes me...
Development of a quantitative assay to measure EBV viral load in patients with autoimmune type 1 diabetes and healthy subjects.
Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers.

Schools

Loyola University of Chicago Stritch School of Medicine
Mayo Clinic Rochester
Stanford University

Doctors Specialties

Hematology
Medical Oncology
Oncology
Internal Medicine

Accepted Insurances

Education

Stanford University
Mayo School of Graduate Medical Education
Loyola University Chicago Stritch School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Jason Boney, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew S. Flewwelling, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer L. Tam, MD This Doctor is OpenDoctor Recommended.
	Dr. Betsy L. Moody, MD This Doctor is OpenDoctor Recommended.
	Dr. Grace Niklas, MD This Doctor is OpenDoctor Recommended.